中文名称: Conoidin A
英文名称: Conoidin A
CAS No: 18080-67-6
分子式: C10H8Br2N2O2
分子量: 347.99
C10790 Conoidin A ≥98% (psaitong)
包装规格:
100mg in glass bottle
溶解性:
溶于DMSO(14.29 mg/mL 超声)
产品描述:

基本信息

产品编号:C10790

产品名称:Conoidin A

CAS:

18080-67-6

 

储存条件

粉末

2-8℃

四年

 

 

分子式:

C10H8Br2N2O2

溶于液体

-80℃

两年

分子量

347.99

-20℃

一个月

化学名: 

2,3-BIS(BROMOMETHYL)-1-OXOQUINOXALIN-1-IUM-4(1H)-OLATE

 

Solubility (25°C)

 

体外

DMSO

70mg/mL (201.15mM)

Ethanol

Insoluble

Water

Insoluble

体内

现配现用

 

1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

2.8736mL

14.3682mL

28.7365mL

5mM

0.5747mL

2.8736mL

5.7473mL

10mM

0.2874mL

1.4368mL

2.8736mL

50mM

0.0575mL

0.2874mL

0.5747mL

 

生物活性

产品描述

刚地弓形虫过氧化物酶 II (TgPrxII) 的细胞通透性抑制剂。

靶点/IC50

T.gondii enzyme peroxiredoxin II (TgPrxII)

IC50: 23µM

 

体外研究

Peroxiredoxins are a widely conserved family of enzymes that function in antioxidant defense and signal transduction. And the changes in PrxII expression are associated with a variety of human diseases, including cancer.Conoidin A binds to the peroxidatic cysteine of TgPrxII, inhibiting its enzymatic activity in vitro. Conoidin A also shown toalkylate or crosslink catalytic cysteines of wild type AcePrx-1 in Ancylostoma ceylanicum and human PrxII and PrxIV with similar efficiency. But it is ineffective to mitochondrial hPrxIII.Conoidin A (5µM) can inhibit the glucose oxidase-mediated hyperoxidation of mammalian peroxiredoxin I and II.

 

体内研究

Conoidin A (intraperitoneal injection; 5mg/kg; for three successive days before MI/R injury) blocks the effect of Luteolin (HYN0162) on the ST‐segment elevation. Furthermore, an increase in the infarct size presented of the MI/R group can be reduced by Luteolin. But pre‐treatment with conoidin A abolishs the effect of Luteolin. Pre‐treatment with conoidin A also prevents Luteolin-reduced activities of CK‐MB, AST and LDH in vivo.

Animal Model:

Rat myocardial I/R model

Dosage:

5mg/kg

Administration:

Intraperitoneal injection; 5mg/kg; for three successive days before MI/R injury

Result:

Intraperitoneal injection; 5mg/kg; for three successive days before MI/R injury

保存条件:
2-8℃
UN码:
HazardClass:
危害声明:
安全说明:
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量,填写另外两个变量

用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:
  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):